Skip to main content

FDA reportedly plans to authorize emergency use of largely untested drug to treat coronavirus

FDA reportedly plans to authorize emergency use of largely untested drug to treat coronavirusThe Food and Drug Administration will authorize the emergency use of the antiviral remdesivir on COVID-19 patients as soon as Wednesday, a senior administration official told The New York Times. Pharmaceutical company Gilead Sciences revealed promising study results involving remdesivir on Wednesday, but the FDA's reported move would still sidestep the usual testing required to authorize a drug's usage.Gilead said Wednesday that its own trial, as well one overseen by the National Institute of Allergy and Infectious Diseases, met its goals. Of the study's 397 severe COVID-19 patients, at least 50 percent of patients treated with a 5-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks. The overall mortality rate of the study was 7 percent, and relatively few patients developed bad side effects. But the study wasn't evaluated against a control group, and it's unclear if those recoveries were natural or if remdesivir actually had something to do with them. Hard data from the study also hasn't been released yet.Anecdotal reports, including two published in The New England Journal of Medicine, provided more credibility for remdesivir in the coronavirus fight. But they also didn't compared the drug against a placebo. A study published in The Lancet concluded remdesivir was "safe and adequately tolerated" but "did not provide significant benefits over placebo."More stories from theweek.com How Tara Reade's allegations could bring down Joe Biden The perils of Hooverism Florida's health department reportedly told medical examiners to remove causes of death from mortality data




from Yahoo News - Latest News & Headlines https://ift.tt/2zzWRCr
via IFTTT

Labels:

Comments

Post a Comment

Popular posts from this blog

Angola takes measures to improve access to safe water and curb cholera - WHO | Regional Office for Africa

Angola takes measures to improve access to safe water and curb cholera    WHO | Regional Office for Africa Africa Centres for Disease Control and Prevention (CDC) Supports Angola to Fight Cholera    ZAWYA Cholera should not be killing anyone in 21st century: WHO    ET HealthWorld World News in Brief: Cholera surges worldwide, DR Congo update, WHO leads global health emergency exercise    UN News WHO sounds alarm over surging global cholera cases in 2025    Arab News from Top stories - Google News https://ift.tt/67xHpr2
Post a Comment
Read more

Iraqi militia vows to back Hizbullah

BEIRUT: The head of the powerful Iraqi militia Harakat al-Nujaba pledged on Tuesday to stand alongside its Lebanese ally Hizbullah if a new war breaks out with Israel. Harakat al-Nujaba and Hizbullah have fought side-by-side to bolster Syrian government troops since 2013, most prominently against the Islamic State group in eastern Syria. On Tuesday, the movement’s secretary general Akram al-Kaabi visited the tomb of top Hizbullah commander Imad Mughniyeh to commemorate the 10 years since his death. "We in the Iraqi resistance stand with Hizbullah, and we will stand with Hizbullah in any Israeli attack or action against it," Kaabi said. He pledged to fight "with Hizbullah in a single row, on a single front, just as we stood with them on a single front in Iraq or Syria." Kaabi spoke in Beirut’s southern suburbs, where Hizbullah has a strong support base. Both Harakat al-Nujaba and Hizbullah are backed by Iran. They fought alongside Syrian government troops and othe...
Post a Comment
Read more